The near-death experience of delta opioid receptors leads to new drug targets.
Ernest Gallo Clinic and Research Center, Emeryville CA 94608, USA.
Selena E
SE
Bartlett
Jennifer L
JL
Whistler
D002462:Cell Membrane / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000737:chemistry / Q000378:metabolism* / Q000648:ultrastructure; D006801:Humans; D008024:Ligands; D018832:Molecular Chaperones; D009271:Naltrexone / Q000494:pharmacology; D017510:Protein Folding; D021381:Protein Transport; D017465:Receptors, Opioid, delta / Q000737:chemistry / Q000378:metabolism*; D015398:Signal Transduction
D008024:Ligands; D018832:Molecular Chaperones; D017465:Receptors, Opioid, delta; D009271:Naltrexone